| 0 (0%) | 09-27 09:29 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 82.81 |
1-year : | 96.72 |
| Resists | First : | 70.9 |
Second : | 82.81 |
| Pivot price | 66.25 |
|||
| Supports | First : | 66.13 |
Second : | 63.18 |
| MAs | MA(5) : | 66.86 |
MA(20) : | 66.34 |
| MA(100) : | 64.32 |
MA(250) : | 67.8  |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 42.4 |
D(3) : | 45.8 |
| RSI | RSI(14): 52.6 |
|||
| 52-week | High : | 84.38 | Low : | 51.9 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ HOLX ] has closed below upper band by 33.4%. Bollinger Bands are 6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 67.45 - 67.79 | 67.79 - 68.12 |
| Low: | 65.09 - 65.43 | 65.43 - 65.78 |
| Close: | 66.65 - 67.2 | 67.2 - 67.76 |
Fri, 26 Sep 2025
Why Hologic (HOLX) Outpaced the Stock Market Today - sharewise.com
Fri, 26 Sep 2025
BTIG Maintains Hologic(HOLX.US) With Hold Rating - 富途牛牛
Fri, 26 Sep 2025
AI Scores Predict Cancer Aggressiveness: Hologic's Mammography Tech Shows Promise in Major Studies - Stock Titan
Wed, 24 Sep 2025
Hologic (HOLX) Jumps 7.7% on Renewed Billion-Dollar Takeover Bid - MSN
Wed, 24 Sep 2025
HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer? - Yahoo Finance
Tue, 23 Sep 2025
Hologic(HOLX.US) Officer Sells US$9.27 Million in Common Stock - 富途牛牛
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 222 (M) |
| Shares Float | 220 (M) |
| Held by Insiders | 0.8 (%) |
| Held by Institutions | 100.9 (%) |
| Shares Short | 3,120 (K) |
| Shares Short P.Month | 4,410 (K) |
| EPS | 2.41 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 21.79 |
| Profit Margin | 13.7 % |
| Operating Margin | 25.4 % |
| Return on Assets (ttm) | 6.6 % |
| Return on Equity (ttm) | 11.3 % |
| Qtrly Rev. Growth | 1.2 % |
| Gross Profit (p.s.) | 11.06 |
| Sales Per Share | 18.16 |
| EBITDA (p.s.) | 5.61 |
| Qtrly Earnings Growth | 4.9 % |
| Operating Cash Flow | 1,070 (M) |
| Levered Free Cash Flow | 760 (M) |
| PE Ratio | 27.88 |
| PEG Ratio | 0 |
| Price to Book value | 3.08 |
| Price to Sales | 3.7 |
| Price to Cash Flow | 13.97 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|